Stefanie Dimmeler appointed as Chief Editor of EMBO Molecular Medicine
The European molecular biology Organization (EMBO) announced the appointment of Professor Stefanie Dimmeler as Chief Editor of the scientific journal EMBO Molecular Medicine. Dr. Dimmeler is Professor of Experimental Medicine and Director of the Institute of Cardiovascular Regeneration, Center for Molecular Medicine at the Goethe University Frankfurt.
In her position as chief editor, Stefanie aims to increase the visibility of the journal across all medical disciplines. She dreams that the journal will one day become the ‘basic science-oriented’ equivalent to the New England Journal of Medicine, with a similar impact. “This will be a long way to go – but worth the effort!” she said.
Professor Dimmeler’s research focuses on endothelial cell biology, including signal transduction apoptosic mechanisms and vascular renewal by circulating endothelial progenitor cells. She has identified novel signalling pathways mediating the synthesis and release of the endothelial protective factor NO (nitric oxide). The scientific discoveries achieved from joint research conducted by Professor Dimmeler and Dr. Andreas M. Zeiher, Professor and Director of the Department of Cardiology, Angiology/Haematology, Nephrology at the Goethe University Frankfurt, have resulted in current clinical trials of human progenitor cells for cardiovascular repair. Her group is presently working on microRNA-based therapeutics for cardiovascular diseases.
After her PhD from the University of Konstanz in Germany, Stefanie Dimmeler completed a fellowship in Experimental Surgery at the University of Cologne and in Molecular Cardiology at the Goethe University Frankfurt. She became Professor of Experimental Medicine at the Institute of Cardiovascular Regeneration, Center for Molecular Medicine, Goethe University Frankfurt in 2001. In 2008, she took on the role of director for the institute.
Other news from the department people
